Overview

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(5)

Status:
Not yet recruiting
Trial end date:
2023-06-13
Target enrollment:
Participant gender:
Summary
A phase I clinical trial to evaluate the tolerability and the pharmacokinetics of CKD-348(5).
Phase:
Phase 1
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical